Trial Profile
Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2011
Price :
$35
*
At a glance
- Drugs Fluvastatin (Primary) ; Interferon alpha; Ribavirin
- Indications Hepatitis C; HIV-1 infections
- Focus Therapeutic Use
- 21 Jun 2011 New trial record